Literature DB >> 2167334

Subclass distribution of the serum and intrathecal IgG antibody response in varicella-zoster virus infections.

J M Echevarría1, A Téllez, P Martínez-Martín.   

Abstract

The subclass distribution of the varicella-zoster virus (VZV)-specific IgG antibody response was studied in serum samples from 22 patients with primary varicella and 34 with recurrent VZV infections and in cerebrospinal fluid (CSF) samples from 22 patients with recurrent infection who presented with symptoms of aseptic meningitis. IgG1 and 3 were the dominant subclasses among patients with primary and recurrent infections; IgG1 was also prevalent in the CSF samples. The VZV IgG subclass distribution patterns did not allow differentiation between primary and recurrent infections. However, seroconversions for IgG2, 3, or 4 were observed among patients with recurrences who were negative for specific IgM, suggesting that qualitative tests for serum IgG subclass antibody could be helpful for diagnosis in such cases. Herpes simplex virus-specific IgG was found in CSF samples from several patients with meningitis. The results suggest that calculation of the antibody to albumin index is better than IgG subclass antibody assays for discriminating the causative agent in these cases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167334     DOI: 10.1093/infdis/162.3.621

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Dual detection of antibody to both herpes simplex and varicella-zoster viruses in cerebrospinal fluid: cross reactivity or dual infection?

Authors:  J M Echevarría; I Casas; A Tenorio; P Martínez-Martín
Journal:  J Neurol       Date:  1996-08       Impact factor: 4.849

Review 2.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

3.  Role of immunoglobulin G subclasses in Q fever.

Authors:  M T Camacho; I Outschoorn; A Tellez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.